Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545700 · ClinicalTrials.gov registry record · Phase 4
Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery
A Phase 4 study, sponsored by Endeavor Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT01545700 is a Phase 4 study that has completed, run by Endeavor Health. The registered enrollment target is 200 participants.
The verdict
NCT01545700, a Phase 4 study, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
The question of a possible hyperglycemic effect from single-dose dexamethasone is an important issue for clinicians managing patients in the intraoperative and postoperative periods. Recent evidence suggests that even moderate elevations in blood glucose levels may be associated with adverse events. The aim of this clinical investigation is to determine whether standard clinical doses of dexamethasone produce hyperglycemia in the perioperative period.
Interventions
- DRUG Control-saline
- DRUG Dexamethasone 4 mg
- DRUG Dexamethasone 8 mg
- DRUG Control saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01545700
The ClinicalTrials.gov registry entry for NCT01545700 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Control-saline is the first listed.
NCT01545700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01545700 about?
NCT01545700 is a clinical study titled "Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery". The question of a possible hyperglycemic effect from single-dose dexamethasone is an important issue for clinicians managing patients in the intraoperative and postoperative periods. Recent evidence suggests that even moderate elevations in blood glucose levels may be associated with adverse events....
What is the current status of trial NCT01545700?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2009-09. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01545700?
The interventions under investigation include: Control-saline (DRUG), Dexamethasone 4 mg (DRUG), Dexamethasone 8 mg (DRUG), Control saline (DRUG).
Who is sponsoring clinical trial NCT01545700?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.